Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Is Imatinib Maintenance Required for Patients with Relapse Chronic Myeloid Leukemia Post-Transplantation Obtaining CMR? A Pilot Retrospective Investigation.

Jin H, Xiong Y, Sun J, Zhang Y, Huang F, Zhou H, Fan Z, Xu D, Wei Y, Dai M, Feng R, Liu Q.

PLoS One. 2013 Jun 18;8(6):e65981. doi: 10.1371/journal.pone.0065981. Print 2013.

2.

Predicting relapse prior to transplantation in chronic myeloid leukemia by integrating expert knowledge and expression data.

Yeung KY, Gooley TA, Zhang A, Raftery AE, Radich JP, Oehler VG.

Bioinformatics. 2012 Mar 15;28(6):823-30. doi: 10.1093/bioinformatics/bts059. Epub 2012 Jan 31.

3.

Technical phosphoproteomic and bioinformatic tools useful in cancer research.

López E, Wesselink JJ, López I, Mendieta J, Gómez-Puertas P, Muñoz SR.

J Clin Bioinforma. 2011 Oct 3;1:26. doi: 10.1186/2043-9113-1-26.

4.

Clinical and technical phosphoproteomic research.

López E, López I, Ferreira A, Sequí J.

Proteome Sci. 2011 Jun 2;9:27. doi: 10.1186/1477-5956-9-27.

5.

Characterization of chronic myeloid leukemia stem cells.

Gerber JM, Qin L, Kowalski J, Smith BD, Griffin CA, Vala MS, Collector MI, Perkins B, Zahurak M, Matsui W, Gocke CD, Sharkis SJ, Levitsky HI, Jones RJ.

Am J Hematol. 2011 Jan;86(1):31-7. doi: 10.1002/ajh.21915.

Supplemental Content

Support Center